Adam D DeVore1, Xiaojuan Mi2, Robert J Mentz3, Gregg C Fonarow4, Melissa K Van Dyke5, Juan F Maya5, N Chantelle Hardy2, Bradley G Hammill2, Adrian F Hernandez3. 1. Duke Clinical Research Institute, Durham, NC; Department of Medicine, Duke University School of Medicine, Durham, NC. Electronic address: adam.devore@duke.edu. 2. Duke Clinical Research Institute, Durham, NC. 3. Duke Clinical Research Institute, Durham, NC; Department of Medicine, Duke University School of Medicine, Durham, NC. 4. Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, CA. 5. Amgen, Inc, Thousand Oaks, CA.
Abstract
BACKGROUND:Elevated heart rate of ≥70 beats/min despite β-blocker use may represent a new treatment target in patients in sinus rhythm with heart failure with reduced ejection fraction. However, little is known about the proportion of patients with elevated heart rate despite β-blocker therapy. METHODS: We analyzed data from a large clinical registry to describe discharge heart rate as a function of β-blocker use and dose. We included patients with left ventricular ejection fraction <40% who were admitted with acute heart failure in 2003 and 2004; we excluded patients with a history of atrial arrhythmia or with a pacemaker or cardiac resynchronization therapy. We considered the β-blockers carvedilol, metoprolol succinate, bisoprolol, atenolol, and metoprolol tartrate and described discharge dose as a percentage of target dose (ie, <25%, 25%-49%, 50%-99%, and ≥100%). RESULTS: Among 10,696 patients, median discharge heart rate was 76 beats/min (interquartile range [IQR] 66-86 beats/min). Of these, 7,826 (73%) were discharged on a β-blocker. For patients not on a β-blocker, median discharge heart rate was 80 beats/min (IQR 70-89 beats/min), compared with 78 beats/min (IQR 69-88 beats/min) on <25% of target dose, 75 beats/min (IQR 66-85 beats/min) on 25% to 49% of target dose, 74 beats/min (IQR 66-82 beats/min) on 50% to 99% of target dose, and 72 beats/min (IQR 65% to 80%) on 100% of target dose or greater (P < .001). Most patients, 7,647 (71%), had a discharge heart rate of ≥70 beats/min, including 1,460 (63%) of 2,301 patients discharged on 50% of target dose or greater. CONCLUSIONS: Despite treatment with β-blockers, a substantial proportion of patients hospitalized with heart failure with reduced ejection fraction have elevated heart rate at discharge.
RCT Entities:
BACKGROUND: Elevated heart rate of ≥70 beats/min despite β-blocker use may represent a new treatment target in patients in sinus rhythm with heart failure with reduced ejection fraction. However, little is known about the proportion of patients with elevated heart rate despite β-blocker therapy. METHODS: We analyzed data from a large clinical registry to describe discharge heart rate as a function of β-blocker use and dose. We included patients with left ventricular ejection fraction <40% who were admitted with acute heart failure in 2003 and 2004; we excluded patients with a history of atrial arrhythmia or with a pacemaker or cardiac resynchronization therapy. We considered the β-blockers carvedilol, metoprolol succinate, bisoprolol, atenolol, and metoprolol tartrate and described discharge dose as a percentage of target dose (ie, <25%, 25%-49%, 50%-99%, and ≥100%). RESULTS: Among 10,696 patients, median discharge heart rate was 76 beats/min (interquartile range [IQR] 66-86 beats/min). Of these, 7,826 (73%) were discharged on a β-blocker. For patients not on a β-blocker, median discharge heart rate was 80 beats/min (IQR 70-89 beats/min), compared with 78 beats/min (IQR 69-88 beats/min) on <25% of target dose, 75 beats/min (IQR 66-85 beats/min) on 25% to 49% of target dose, 74 beats/min (IQR 66-82 beats/min) on 50% to 99% of target dose, and 72 beats/min (IQR 65% to 80%) on 100% of target dose or greater (P < .001). Most patients, 7,647 (71%), had a discharge heart rate of ≥70 beats/min, including 1,460 (63%) of 2,301 patients discharged on 50% of target dose or greater. CONCLUSIONS: Despite treatment with β-blockers, a substantial proportion of patients hospitalized with heart failure with reduced ejection fraction have elevated heart rate at discharge.
Authors: Raban V Jeger; Otmar Pfister; Dragana Radovanovic; Franz R Eberli; Hans Rickli; Philip Urban; Giovanni Pedrazzini; Jean-Christophe Stauffer; Jörg Nossen; Paul Erne Journal: Clin Cardiol Date: 2017-06-09 Impact factor: 2.882
Authors: Lotte E de Groot-de Laat; Jessy Huizer; Mattie Lenzen; Ernest Spitzer; Ben Ren; Marcel L Geleijnse; Kadir Caliskan Journal: ESC Heart Fail Date: 2019-08-07
Authors: Daniel Weng; Jie Ding; Apurva Sharma; Lisa Yanek; Helen Xun; Erin M Spaulding; Ngozi Osuji; Pauline P Huynh; Oluseye Ogunmoroti; Matthias A Lee; Ryan Demo; Francoise A Marvel; Seth S Martin Journal: Cardiovasc Digit Health J Date: 2021-05-12